Your search for comorbidities returned 110 results

A study was conducted to determine clinical indicators for post-ablation symptoms following catheter ablation for atrial fibrillation.

A study was conducted to determine the safety and efficacy of LAAO and DOACs over 5 years in patients with NVAF and high bleeding risk.

A study was conducted to examine the effect of dexmedetomidine therapy on incidence of new-onset atrial fibrillation in patients who are critically ill.

A study was conducted to determine the effect of SGLT2 inhibitors on risk for atrial fibrillation in patients with heart failure.

A study was conducted to determine temporal changes to incidence rates of atrial fibrillation or flutter in patients younger than 65 years.

Louise Pilote, MD, Annabelle Santos Volgman, MD, and Salvatore Savona, MD, discuss sex-based health disparities in atrial fibrillation.

In a prospective, observational study, researchers investigated the prevalence of silent AF and associated risk factors in patients assessed for OSA or with known OSA.

Researchers compared the real-world effectiveness of amiodarone vs dronedarone among patients hospitalized for atrial fibrillation.

A study was conducted to determine the relationship between obesity in male adolescence and development of atrial fibrillation later in life.

Researchers sought to determine the effect of electronic monitoring plus pharmacist-led educational interventional programs in patients with NVAF receiving DOACs.